drugset / Trial / NCT03852446
Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers
RandomizedCrossoverQuadruple-blindTreatment
Summary
This 2-part study will assess the effect of formulation and food on the pharmacokinetics of Indoximod in healthy volunteers. Part 1 is a randomized single ascending dose study of indoximod salt formulation to characterize the PK profile and determine the safety and tolerability of each dose in healthy male volunteers. Part 2 is an open-label, randomized, 3-period, 3-way crossover study. Participants will receive single doses of Indoximod base or salt formulation, in the fasted or fed state.
Timeline
- Start
- 2018-03-05
- Primary completion
- 2018-03-05
- Completion
- 2018-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indoximod | Small molecule | 600 mg | Oral |
| Subject | Indoximod | Small molecule | 1200 mg | Oral |
| Subject | Indoximod | Small molecule | 2400 mg | Oral |
Indications
No indication recorded.